
# depot <img src = "vignette/img/mrgsolve_hex.png" align="right" width="120px"></img>

## azithro

  - Type: Population PK
  - Links: [model](inst/models/azithro.cpp)
    [vignette](vignette/azithro.md)

**Reference** Zhao Q, Tensfeldt TG, Chandra R, Mould DR. *Population
pharmacokinetics of azithromycin and chloroquine in healthy adults and
paediatric malaria subjects following oral administration of fixed-dose
azithromycin and chloroquine combination tablets*. Malar J. 2014 Jan
29;13:36. <doi:10.1186/1475-2875-13-36>. PubMed PMID: 24472224; PubMed
Central PMCID: PMC3909452.

## cipro

  - Type: PBPK
  - Links: [model](inst/models/cipro.cpp) [vignette](vignette/cipro.md)

**Reference** Sadiq MW, Nielsen EI, Khachman D, Conil JM, Georges B,
Houin G, Laffont CM, Karlsson MO, Friberg LE. A whole-body
physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin:
a step towards predicting bacterial killing at sites of infection. J
Pharmacokinet Pharmacodyn. 2017 Apr;44(2):69-79. doi:
10.1007/s10928-016-9486-9. Epub 2016 Aug 30. PubMed PMID: 27578330;
PubMed Central PMCID: PMC5376394.

## gcsf

  - Type: TMDD
  - Links: [model](inst/models/gcsf.cpp) [vignette](vignette/gcsf.md)

**Reference** Krzyzanski W, Wiczling P, Lowe P, Pigeolet E, Fink M,
Berghout A, Balser S. Population modeling of filgrastim PK-PD in healthy
adults following intravenous and subcutaneous administrations. J Clin
Pharmacol. 2010 Sep;50(9 Suppl):101S-112S. doi:
10.1177/0091270010376966. PubMed PMID: 20881223.
